The UK Competition Authority deems a merger between two veterinary firms as likely to be anti-competitive and gives the firm time to offer remedies or will proceed with a phase II investigation (VetPartners / Goddard)

VetPartners’ purchase of Goddard raises competition concerns* VetPartners’ completed purchase of Goddard could now be referred for an in-depth investigation after the CMA found that the deal raises competition concerns. The Competition and Markets Authority (CMA) opened its investigation into VetPartners Limited’s purchase of Goddard Holdco Limited, which trades as Goddard Veterinary Group, in March 2022. Both firms are providers of veterinary services. VetPartners, owned by the private equity firm BC Partners, operates approximately 550 sites across the UK, while Goddard, a family-owned business, operates 47 sites in Greater London. As with the CMA’s recent investigation into CVS’s purchase of The Vet , this deal takes place against a backdrop of a small number of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • United Kingdom’s Competition Authority - CMA (London)

Quotation

UK Competition Authority, The UK Competition Authority deems a merger between two veterinary firms as likely to be anti-competitive and gives the firm time to offer remedies or will proceed with a phase II investigation (VetPartners / Goddard), 28 April 2022, e-Competitions April 2022, Art. N° 106386

Visites 236

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues